Glyscend, Inc.

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Ashish Nimgaonkar (5 out of 9 patents)

Steven C Polomoscanik (5 out of 5 patents)

Thomas Henry Jozefiak (5 out of 20 patents)

5 patents: Sort by Forward Citations

1. 12059432 - Substituted phenyl boronic acid containing polymers and methods of use (2024-08-13),

2. 11576928 - Substituted phenyl boronic acid containing polymers and methods of use (2023-02-14),

3. 11491183 - Substituted phenyl boronic acid containing polymers and methods of use (2022-11-08),

4. 11491182 - Substituted phenyl boronic acid containing polymers and methods of use (2022-11-08),

5. 11484548 - Substituted phenyl boronic acid containing polymers and methods of use (2022-11-01),

Company Overview

Glyscend, Inc. is a biotechnology company focused on the development of novel therapies for metabolic diseases. The company's flagship product is an innovative oral therapy for diabetes, designed to improve glycaemic control without the need for injections. Glyscend is dedicated to revolutionizing the way diabetes is managed, offering patients a more convenient and effective treatment option.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#102 in Baltimore, MD

#751 in Maryland

#51,644 in US

Baltimore, MD, United States of America

Glyscend, Inc.

Forward Citations = 4

3 inventors:

Ashish Nimgaonkar (5 out of 9 patents)

Steven C Polomoscanik (5 out of 5 patents)

Thomas Henry Jozefiak (5 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glyscend, Inc.. Retrieved from https://idiyas.com/company/glyscend

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]